Terms: = Sarcomas AND BCORL1, ENSG00000085185, 63035, FLJ11362, RP3-510O21_1, B930011H20Rik
36109 results:
1. Glycolic acid and D-lactate-putative products of DJ-1-restore neurodegeneration in FUS - and SOD1-ALS.
Pal A; Grossmann D; Glaß H; Zimyanin V; Günther R; Catinozzi M; Boeckers TM; Sterneckert J; Storkebaum E; Petri S; Wegner F; Grill SW; Pan-Montojo F; Hermann A
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38760174
[TBL] [Abstract] [Full Text] [Related]
2. HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?
Becker AK; Puladi B; Xie K; Cassataro A; Götzl R; Hölzle F; Beier JP; Knüchel-Clarke R; Braunschweig T
World J Surg Oncol; 2024 May; 22(1):131. PubMed ID: 38760830
[TBL] [Abstract] [Full Text] [Related]
3. A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020.
Mousavi SE; Najafi M; Aslani A; Fazlollahi A; Yekta Z; Sadri M; Nejadghaderi SA
Sci Rep; 2024 May; 14(1):11294. PubMed ID: 38760399
[TBL] [Abstract] [Full Text] [Related]
4. PARP1-DNA co-condensation: the driver of broken DNA repair.
Wei X; Zhou F; Zhang L
Signal Transduct Target Ther; 2024 May; 9(1):135. PubMed ID: 38760366
[TBL] [Abstract] [Full Text] [Related]
5. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
[TBL] [Abstract] [Full Text] [Related]
6. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
[TBL] [Abstract] [Full Text] [Related]
7. Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
Gargett T; Truong NTH; Gardam B; Yu W; Ebert LM; Johnson A; Yeo ECF; Wittwer NL; Tapia Rico G; Logan J; Sivaloganathan P; Collis M; Ruszkiewicz A; Brown MP
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754916
[TBL] [Abstract] [Full Text] [Related]
8. Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.
Nasri E; Torrence DE; Vasilopoulos T; Knapik JA; Lagmay JP; Reith JD; Gibbs CP
Cancer J; 2024 May-Jun 01; 30(3):133-139. PubMed ID: 38753746
[TBL] [Abstract] [Full Text] [Related]
9. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
[TBL] [Abstract] [Full Text] [Related]
10. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract] [Full Text] [Related]
11. Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma.
Thongkumkoon P; Sangphukieo A; Tongjai S; Noisagul P; Sangkhathat S; Laochareonsuk W; Kamolphiwong R; Budprom P; Teeyakasem P; Yongpitakwattana P; Thepbundit V; Sirikaew N; Klangjorhor J; Settakorn J; Moonmuang S; Suksakit P; Pasena A; Chaijaruwanich J; Yathongkhum W; Dissook S; Pruksakorn D; Chaiyawat P
Sci Rep; 2024 May; 14(1):11056. PubMed ID: 38744935
[TBL] [Abstract] [Full Text] [Related]
12. mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism.
Levy T; Voeltzke K; Hruby L; Alasad K; Bas Z; Snaebjörnsson M; Marciano R; Scharov K; Planque M; Vriens K; Christen S; Funk CM; Hassiepen C; Kahler A; Heider B; Picard D; Lim JKM; Stefanski A; Bendrin K; Vargas-Toscano A; Kahlert UD; Stühler K; Remke M; Elkabets M; Grünewald TGP; Reichert AS; Fendt SM; Schulze A; Reifenberger G; Rotblat B; Leprivier G
Nat Commun; 2024 May; 15(1):4083. PubMed ID: 38744825
[TBL] [Abstract] [Full Text] [Related]
13. Proposed diagnostic and prognostic markers of primary malignant hepatic vascular neoplasms.
Yoo Y; Shin J; Jun E; Koh EY; Shin HJ; Kang HJ
Diagn Pathol; 2024 May; 19(1):68. PubMed ID: 38741104
[TBL] [Abstract] [Full Text] [Related]
14. Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours.
Zago Baltazar R; Claerhout S; Vander Borght S; Spans L; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Renard M; van den Hout MF; Vernemmen A; Libbrecht L; De Roo AK; Mazzeo F; van Marcke C; Deraedt K; Bourgain C; Vanden Bempt I
J Pathol Clin Res; 2024 May; 10(3):e12376. PubMed ID: 38738521
[TBL] [Abstract] [Full Text] [Related]
15. A 16-Year-Old Girl with Sinonasal Cutaneous Fistula Following Excision and Radiotherapy for Rhabdomyosarcoma Requiring Reconstructive Surgery Using an Expanded Forehead Flap.
Wang Q; Yang X; Liang Y; Wang C; Zhou R
Am J Case Rep; 2024 May; 25():e943098. PubMed ID: 38736220
[TBL] [Abstract] [Full Text] [Related]
16. Chondrosarcoma evaluation using hematein-based x-ray staining and high-resolution 3D micro-CT: a feasibility study.
Gersing AS; Kimm MA; Bollwein C; Ilg P; Mogler C; Gassert FG; Feuerriegel GC; Knebel C; Woertler K; Pfeiffer D; Busse M; Pfeiffer F
Eur Radiol Exp; 2024 May; 8(1):58. PubMed ID: 38735899
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer.
Shreenivas A; Nishizaki D; Lee S; Pabla S; Nesline M; Conroy JM; DePietro P; Kato S; Kurzrock R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731962
[TBL] [Abstract] [Full Text] [Related]
18. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
[TBL] [Abstract] [Full Text] [Related]
19. Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
Kho S; Seung KJ; Huerga H; Bastard M; Khan PY; Mitnick CD; Rich ML; Islam S; Zhizhilashvili D; Yeghiazaryan L; Nikolenko EN; Zarli K; Adnan S; Salahuddin N; Ahmed S; Vargas ZHR; Bekele A; Shaimerdenova A; Tamirat M; Gelin A; Vilbrun SC; Hewison C; Khan U; Franke M
Nat Commun; 2024 May; 15(1):3927. PubMed ID: 38724531
[TBL] [Abstract] [Full Text] [Related]
20. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.
Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Røsok B; Joensuu H; Bruland Ø
Acta Oncol; 2024 May; 63():288-293. PubMed ID: 38712513
[TBL] [Abstract] [Full Text] [Related]
[Next]
